A 2017 CDC network of laboratories to hasten the identification of and response to so-called “nightmare bacteria" was successful in providing health officials with additional information about control and treatment measures.

A smartphone application utilizing a camera to assess blood flow in the wrist artery in patients undergoing coronary angiography was able to outperform traditional physical examination, according to a study published April 3 in Canadian Medical Association Journal.

The new research from Research2Guidance, a Berlin-based market research company focused on mobile app development, included 2,400 mHealth developers and healthcare professionals, with 47 percent of responses coming from Europe and 36 percent from the U.S.

Scientists at the University of California, Davis have been able to grow vascularized human neural organoids by taking brain membrane cells from patients—and then coaxed some of them into stem cells.

Researchers from the Inspired Nanomaterials and Tissue Engineering Laboratory have developed an injectable bandage made of a hydrogel agent, according to a study published in the February 2018 edition of Acta Biomaterialia.

GE Healthcare has announced it will sell its revenue cycle, ambulatory care and workforce management software units to private equity firm Veritas Capital for $1.05 billion, following earlier plans for General Electric to sell assets and rumors the entire company could be broken up.

A bundled payment arrangement created in Texas by a non-profit Medicaid health maintenance organization (HMO) didn’t result in consistent savings for the two large physician groups participating, according to research displayed at the American College of Healthcare Executives (ACHE) Congress in Chicago.

A recent small-sample survey published online March 22 in Genetics in Medicine found direct-to-consumer DNA tests may produce false-positives in 40 percent of variants when subjected to clinical confirmation testing.